ID NDOR1_HUMAN Reviewed; 597 AA. AC Q9UHB4; D3YTG6; D3YTH9; Q5VSG4; Q86US9; Q96BC6; DT 26-FEB-2008, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-2000, sequence version 1. DT 28-JAN-2026, entry version 183. DE RecName: Full=NADPH-dependent diflavin oxidoreductase 1 {ECO:0000255|HAMAP-Rule:MF_03178}; DE EC=1.18.1.- {ECO:0000255|HAMAP-Rule:MF_03178, ECO:0000269|PubMed:23596212, ECO:0000269|PubMed:28648056}; DE AltName: Full=NADPH-dependent FMN and FAD-containing oxidoreductase {ECO:0000255|HAMAP-Rule:MF_03178}; DE AltName: Full=Novel reductase 1 {ECO:0000303|PubMed:10625700}; GN Name=NDOR1 {ECO:0000255|HAMAP-Rule:MF_03178}; GN Synonyms=NR1 {ECO:0000303|PubMed:10625700}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, COFACTOR, RP BIOPHYSICOCHEMICAL PROPERTIES, AND SUBCELLULAR LOCATION. RX PubMed=10625700; DOI=10.1074/jbc.275.2.1471; RA Paine M.J., Garner A.P., Powell D., Sibbald J., Sales M., Pratt N., RA Smith T., Tew D.G., Wolf C.R.; RT "Cloning and characterization of a novel human dual flavin reductase."; RL J. Biol. Chem. 275:1471-1478(2000). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBCELLULAR LOCATION, AND TISSUE RP SPECIFICITY. RC TISSUE=Brain; RX PubMed=12871939; DOI=10.1074/jbc.m306355200; RA Kwasnicka D.A., Krakowiak A., Thacker C., Brenner C., Vincent S.R.; RT "Coordinate expression of NADPH-dependent flavin reductase, Fre-1, and RT Hint-related 7meGMP-directed hydrolase, DCS-1."; RL J. Biol. Chem. 278:39051-39058(2003). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3). RC TISSUE=Hippocampus, and Umbilical vein endothelial cell; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15164053; DOI=10.1038/nature02465; RA Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., RA Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., RA Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., RA Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K., RA Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y., RA Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C., RA Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E., RA Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M., RA Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J., RA Frankish A., Frankland J.A., French L., Fricker D.G., Garner P., RA Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S., RA Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E., RA Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D., RA Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E., RA Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K., RA Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S., RA Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J., RA Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E., RA McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V., RA Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S., RA Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K., RA Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J., RA Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., RA West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L., RA Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M., RA Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J., RA Dunham I.; RT "DNA sequence and analysis of human chromosome 9."; RL Nature 429:369-374(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ILE-522. RC TISSUE=Brain, and Skin; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP PROTEIN SEQUENCE OF 1-8, FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=12871938; DOI=10.1074/jbc.m306282200; RA Olteanu H., Banerjee R.; RT "Redundancy in the pathway for redox regulation of mammalian methionine RT synthase: reductive activation by the dual flavoprotein, novel reductase RT 1."; RL J. Biol. Chem. 278:38310-38314(2003). RN [7] RP FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=12631275; DOI=10.1046/j.1432-1033.2003.03474.x; RA Finn R.D., Basran J., Roitel O., Wolf C.R., Munro A.W., Paine M.J., RA Scrutton N.S.; RT "Determination of the redox potentials and electron transfer properties of RT the FAD- and FMN-binding domains of the human oxidoreductase NR1."; RL Eur. J. Biochem. 270:1164-1175(2003). RN [8] RP INTERACTION WITH DCPS, AND CYTOTOXICITY. RX PubMed=16140270; DOI=10.1016/j.bbrc.2005.08.129; RA Kwasnicka-Crawford D.A., Vincent S.R.; RT "Role of a novel dual flavin reductase (NR1) and an associated histidine RT triad protein (DCS-1) in menadione-induced cytotoxicity."; RL Biochem. Biophys. Res. Commun. 336:565-571(2005). RN [9] RP FUNCTION, AND INTERACTION WITH CIAPIN1. RX PubMed=20802492; DOI=10.1038/nchembio.432; RA Netz D.J., Stumpfig M., Dore C., Muhlenhoff U., Pierik A.J., Lill R.; RT "Tah18 transfers electrons to Dre2 in cytosolic iron-sulfur protein RT biogenesis."; RL Nat. Chem. Biol. 6:758-765(2010). RN [10] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [11] RP FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=28648056; DOI=10.1021/jacs.7b05003; RA Camponeschi F., Ciofi-Baffoni S., Banci L.; RT "Anamorsin/Ndor1 Complex Reduces [2Fe-2S]-MitoNEET via a Transient Protein- RT Protein Interaction."; RL J. Am. Chem. Soc. 139:9479-9482(2017). RN [12] RP X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-161 IN COMPLEX WITH FMN, RP FUNCTION, COFACTOR, INTERACTION WITH CIAPIN1, AND CATALYTIC ACTIVITY. RX PubMed=23596212; DOI=10.1073/pnas.1302378110; RA Banci L., Bertini I., Calderone V., Ciofi-Baffoni S., Giachetti A., RA Jaiswal D., Mikolajczyk M., Piccioli M., Winkelmann J.; RT "Molecular view of an electron transfer process essential for iron-sulfur RT protein biogenesis."; RL Proc. Natl. Acad. Sci. U.S.A. 110:7136-7141(2013). RN [13] RP VARIANT ILE-522, CHARACTERIZATION OF VARIANT ILE-522, FUNCTION, AND RP BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=15900210; DOI=10.1097/01213011-200506000-00002; RA Finn R.D., Wilkie M., Smith G., Paine M.J.; RT "Identification of a functionally impaired allele of human novel RT oxidoreductase 1 (NDOR1), NDOR1*1."; RL Pharmacogenet. Genomics 15:381-386(2005). CC -!- FUNCTION: NADPH-dependent reductase which is a central component of the CC cytosolic iron-sulfur (Fe-S) protein assembly (CIA) machinery CC (PubMed:10625700, PubMed:15900210, PubMed:20802492, PubMed:23596212, CC PubMed:28648056). Transfers electrons from NADPH via its FAD and FMN CC prosthetic groups to the [2Fe-2S] cluster of CIAPIN1, another key CC component of the CIA machinery (PubMed:20802492, PubMed:23596212, CC PubMed:28648056). In turn, this reduced cluster provides electrons for CC assembly of cytosolic iron-sulfur cluster proteins (PubMed:20802492, CC PubMed:23596212). It can also reduce the [2Fe-2S] cluster of CISD1 and CC activate this protein implicated in Fe/S cluster repair CC (PubMed:28648056). In vitro can fully activate methionine synthase/MTR CC in the presence of soluble cytochrome b5/CYB5A (PubMed:12871938). CC {ECO:0000255|HAMAP-Rule:MF_03178, ECO:0000269|PubMed:10625700, CC ECO:0000269|PubMed:12871938, ECO:0000269|PubMed:15900210, CC ECO:0000269|PubMed:20802492, ECO:0000269|PubMed:23596212, CC ECO:0000269|PubMed:28648056}. CC -!- CATALYTIC ACTIVITY: CC Reaction=2 oxidized [2Fe-2S]-[protein] + NADPH = 2 reduced [2Fe-2S]- CC [protein] + NADP(+) + H(+); Xref=Rhea:RHEA:67716, Rhea:RHEA- CC COMP:17327, Rhea:RHEA-COMP:17328, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:33737, ChEBI:CHEBI:33738, ChEBI:CHEBI:57783, CC ChEBI:CHEBI:58349; Evidence={ECO:0000255|HAMAP-Rule:MF_03178, CC ECO:0000269|PubMed:23596212, ECO:0000269|PubMed:28648056}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67717; CC Evidence={ECO:0000255|HAMAP-Rule:MF_03178, CC ECO:0000305|PubMed:23596212}; CC -!- COFACTOR: CC Name=FAD; Xref=ChEBI:CHEBI:57692; CC Evidence={ECO:0000255|HAMAP-Rule:MF_03178, CC ECO:0000269|PubMed:10625700}; CC -!- COFACTOR: CC Name=FMN; Xref=ChEBI:CHEBI:58210; CC Evidence={ECO:0000255|HAMAP-Rule:MF_03178, CC ECO:0000269|PubMed:10625700, ECO:0000269|PubMed:23596212}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=21 uM for cytochrome c {ECO:0000269|PubMed:10625700}; CC KM=1.08 uM for NADPH {ECO:0000269|PubMed:12631275, CC ECO:0000269|PubMed:15900210, ECO:0000269|PubMed:23596212}; CC Vmax=1.2 umol/min/ug enzyme for cytochrome c reduction CC {ECO:0000269|PubMed:10625700}; CC Vmax=1.98 umol/min/ug enzyme for cytochrome c reduction CC {ECO:0000269|PubMed:12871938}; CC Vmax=2.8 umol/min/ug enzyme for methionine synthase reductive CC activation {ECO:0000269|PubMed:12871938}; CC pH dependence: CC Optimum pH is about 8.0. {ECO:0000305|PubMed:10625700}; CC Redox potential: CC E(0) is -315 +/- 5 mV for the FAD oxidized/semiquinone couple, E(0) CC is -365 +/- 15 mV for the FAD semiquinone/dihydroquinone couple, E(0) CC is -146 +/- 5 mV for the FMN oxidized/semiquinone couple, and E(0) is CC -305 +/- 5 mV for the FMN semiquinone/dihydroquinone couple. CC {ECO:0000269|PubMed:12631275}; CC -!- SUBUNIT: Interacts with CIAPIN1; as part of the cytosolic iron-sulfur CC (Fe-S) protein assembly (CIA) machinery (By similarity) CC (PubMed:20802492, PubMed:23596212). Interacts with DCPS CC (PubMed:16140270). {ECO:0000255|HAMAP-Rule:MF_03178, CC ECO:0000269|PubMed:16140270, ECO:0000269|PubMed:20802492, CC ECO:0000269|PubMed:23596212}. CC -!- INTERACTION: CC Q9UHB4; Q86UT8: CENATAC; NbExp=3; IntAct=EBI-10249760, EBI-11028020; CC Q9UHB4; Q6FI81: CIAPIN1; NbExp=16; IntAct=EBI-10249760, EBI-750511; CC Q9UHB4; Q5JST6: EFHC2; NbExp=3; IntAct=EBI-10249760, EBI-2349927; CC Q9UHB4; O95995: GAS8; NbExp=3; IntAct=EBI-10249760, EBI-1052570; CC Q9UHB4; O76003: GLRX3; NbExp=2; IntAct=EBI-10249760, EBI-374781; CC Q9UHB4; Q13227: GPS2; NbExp=5; IntAct=EBI-10249760, EBI-713355; CC Q9UHB4; P14652: HOXB2; NbExp=3; IntAct=EBI-10249760, EBI-5329558; CC Q9UHB4; Q6ZU52: KIAA0408; NbExp=3; IntAct=EBI-10249760, EBI-739493; CC Q9UHB4; P25791-3: LMO2; NbExp=3; IntAct=EBI-10249760, EBI-11959475; CC Q9UHB4; Q8TAP4-4: LMO3; NbExp=3; IntAct=EBI-10249760, EBI-11742507; CC Q9UHB4; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-10249760, EBI-739832; CC Q9UHB4; P50221: MEOX1; NbExp=3; IntAct=EBI-10249760, EBI-2864512; CC Q9UHB4; Q5JR59: MTUS2; NbExp=4; IntAct=EBI-10249760, EBI-742948; CC Q9UHB4; Q5JR59-3: MTUS2; NbExp=3; IntAct=EBI-10249760, EBI-11522433; CC Q9UHB4; Q15742: NAB2; NbExp=3; IntAct=EBI-10249760, EBI-8641936; CC Q9UHB4; Q9UBE8: NLK; NbExp=3; IntAct=EBI-10249760, EBI-366978; CC Q9UHB4; P28072: PSMB6; NbExp=3; IntAct=EBI-10249760, EBI-359288; CC Q9UHB4; P15884: TCF4; NbExp=4; IntAct=EBI-10249760, EBI-533224; CC Q9UHB4; P15884-3: TCF4; NbExp=3; IntAct=EBI-10249760, EBI-13636688; CC Q9UHB4; Q9BT92: TCHP; NbExp=7; IntAct=EBI-10249760, EBI-740781; CC Q9UHB4; Q96N21: TEPSIN; NbExp=3; IntAct=EBI-10249760, EBI-11139477; CC Q9UHB4; Q08117-2: TLE5; NbExp=3; IntAct=EBI-10249760, EBI-11741437; CC Q9UHB4; Q9UMX0: UBQLN1; NbExp=3; IntAct=EBI-10249760, EBI-741480; CC Q9UHB4; Q9UHD9: UBQLN2; NbExp=3; IntAct=EBI-10249760, EBI-947187; CC Q9UHB4; B2RXF5: ZBTB42; NbExp=5; IntAct=EBI-10249760, EBI-12287587; CC Q9UHB4; Q53FD0-2: ZC2HC1C; NbExp=3; IntAct=EBI-10249760, EBI-14104088; CC Q9UHB4; Q6ZNG0: ZNF620; NbExp=3; IntAct=EBI-10249760, EBI-4395669; CC Q9UHB4; Q6NX45: ZNF774; NbExp=3; IntAct=EBI-10249760, EBI-10251462; CC -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000255|HAMAP- CC Rule:MF_03178, ECO:0000269|PubMed:10625700, CC ECO:0000269|PubMed:12871939}. Note=Concentrated in perinuclear CC structure. {ECO:0000255|HAMAP-Rule:MF_03178, CC ECO:0000269|PubMed:12871939}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=4; CC Name=1; CC IsoId=Q9UHB4-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9UHB4-2; Sequence=VSP_031487; CC Name=3; CC IsoId=Q9UHB4-3; Sequence=VSP_046313, VSP_046314; CC Name=4; CC IsoId=Q9UHB4-4; Sequence=VSP_053807; CC -!- TISSUE SPECIFICITY: Low expression in brain, heart, kidney, pancreas, CC prostate and skeletal muscle. Highest levels in the placenta. Expressed CC in cancer cell lines including promyelocytic leukemia, HeLaS3, chronic CC myelagenous leukemia, lymphoblastic leukemia, Burkitt's lymphoma, CC colorectal adenocarcinoma, lung carcinoma, and melanoma G-361. CC {ECO:0000269|PubMed:12871939}. CC -!- SIMILARITY: Belongs to the NADPH-dependent diflavin oxidoreductase CC NDOR1 family. {ECO:0000255|HAMAP-Rule:MF_03178}. CC -!- SIMILARITY: In the N-terminal section; belongs to the flavodoxin CC family. {ECO:0000255|HAMAP-Rule:MF_03178}. CC -!- SIMILARITY: In the C-terminal section; belongs to the flavoprotein CC pyridine nucleotide cytochrome reductase family. {ECO:0000255|HAMAP- CC Rule:MF_03178}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF199509; AAF25205.1; -; mRNA. DR EMBL; AY077845; AAL77754.1; -; mRNA. DR EMBL; AK074403; -; NOT_ANNOTATED_CDS; mRNA. DR EMBL; AK290026; BAF82715.1; -; mRNA. DR EMBL; AL929554; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BX255925; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC015735; AAH15735.1; -; mRNA. DR EMBL; BC093782; AAH93782.1; -; mRNA. DR EMBL; BC111943; AAI11944.1; -; mRNA. DR CCDS; CCDS48061.1; -. [Q9UHB4-2] DR CCDS; CCDS48062.1; -. [Q9UHB4-4] DR CCDS; CCDS48063.1; -. [Q9UHB4-3] DR CCDS; CCDS7036.1; -. [Q9UHB4-1] DR RefSeq; NP_001137498.1; NM_001144026.3. [Q9UHB4-2] DR RefSeq; NP_001137499.1; NM_001144027.3. [Q9UHB4-3] DR RefSeq; NP_001137500.1; NM_001144028.3. [Q9UHB4-4] DR RefSeq; NP_055249.1; NM_014434.4. [Q9UHB4-1] DR PDB; 4H2D; X-ray; 1.80 A; A/B=1-161. DR PDBsum; 4H2D; -. DR AlphaFoldDB; Q9UHB4; -. DR SMR; Q9UHB4; -. DR BioGRID; 118038; 54. DR ComplexPortal; CPX-26562; Anamorsin-NDOR1 complex. DR FunCoup; Q9UHB4; 2917. DR IntAct; Q9UHB4; 41. DR STRING; 9606.ENSP00000360576; -. DR GlyCosmos; Q9UHB4; 2 sites, 1 glycan. DR GlyGen; Q9UHB4; 2 sites, 1 O-linked glycan (2 sites). DR iPTMnet; Q9UHB4; -. DR PhosphoSitePlus; Q9UHB4; -. DR BioMuta; NDOR1; -. DR DMDM; 74735011; -. DR jPOST; Q9UHB4; -. DR MassIVE; Q9UHB4; -. DR PaxDb; 9606-ENSP00000360576; -. DR PeptideAtlas; Q9UHB4; -. DR ProteomicsDB; 12813; -. DR ProteomicsDB; 12819; -. DR ProteomicsDB; 84294; -. [Q9UHB4-1] DR ProteomicsDB; 84295; -. [Q9UHB4-2] DR Pumba; Q9UHB4; -. DR Antibodypedia; 18959; 224 antibodies from 25 providers. DR DNASU; 27158; -. DR Ensembl; ENST00000371521.8; ENSP00000360576.4; ENSG00000188566.16. [Q9UHB4-2] DR Ensembl; ENST00000427047.6; ENSP00000394309.1; ENSG00000188566.16. [Q9UHB4-3] DR Ensembl; ENST00000458322.2; ENSP00000389905.1; ENSG00000188566.16. [Q9UHB4-4] DR Ensembl; ENST00000684003.1; ENSP00000507194.1; ENSG00000188566.16. [Q9UHB4-1] DR GeneID; 27158; -. DR KEGG; hsa:27158; -. DR MANE-Select; ENST00000684003.1; ENSP00000507194.1; NM_014434.4; NP_055249.1. DR UCSC; uc004clw.4; human. [Q9UHB4-1] DR AGR; HGNC:29838; -. DR ClinPGx; PA134885020; -. DR CTD; 27158; -. DR DisGeNET; 27158; -. DR GeneCards; NDOR1; -. DR HGNC; HGNC:29838; NDOR1. DR HPA; ENSG00000188566; Low tissue specificity. DR MIM; 606073; gene. DR OpenTargets; ENSG00000188566; -. DR VEuPathDB; HostDB:ENSG00000188566; -. DR eggNOG; KOG1159; Eukaryota. DR GeneTree; ENSGT00930000151050; -. DR HOGENOM; CLU_001570_17_6_1; -. DR InParanoid; Q9UHB4; -. DR OMA; DIMSIPR; -. DR OrthoDB; 1856718at2759; -. DR PAN-GO; Q9UHB4; 4 GO annotations based on evolutionary models. DR PhylomeDB; Q9UHB4; -. DR BRENDA; 1.5.1.30; 2681. DR PathwayCommons; Q9UHB4; -. DR Reactome; R-HSA-2564830; Cytosolic iron-sulfur cluster assembly. DR SignaLink; Q9UHB4; -. DR Agora; ENSG00000188566; -. DR BioGRID-ORCS; 27158; 656 hits in 1148 CRISPR screens. DR ChiTaRS; NDOR1; human. DR EvolutionaryTrace; Q9UHB4; -. DR GeneWiki; NDOR1; -. DR GenomeRNAi; 27158; -. DR Pharos; Q9UHB4; Tbio. DR PRO; PR:Q9UHB4; -. DR Proteomes; UP000005640; Chromosome 9. DR RNAct; Q9UHB4; protein. DR Bgee; ENSG00000188566; Expressed in granulocyte and 94 other cell types or tissues. DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB. DR GO; GO:0005829; C:cytosol; IDA:HPA. DR GO; GO:0045111; C:intermediate filament cytoskeleton; IDA:HPA. DR GO; GO:0005654; C:nucleoplasm; IDA:HPA. DR GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0009055; F:electron transfer activity; IDA:UniProtKB. DR GO; GO:0071949; F:FAD binding; IDA:UniProtKB. DR GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central. DR GO; GO:0010181; F:FMN binding; IDA:UniProtKB. DR GO; GO:0050661; F:NADP binding; IDA:UniProtKB. DR GO; GO:0070402; F:NADPH binding; IDA:UniProtKB. DR GO; GO:0003958; F:NADPH-hemoprotein reductase activity; IDA:UniProtKB. DR GO; GO:0160246; F:NADPH-iron-sulfur [2Fe-2S] protein oxidoreductase activity; IDA:UniProtKB. DR GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central. DR GO; GO:0016653; F:oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor; IDA:UniProtKB. DR GO; GO:0022900; P:electron transport chain; IDA:UniProtKB. DR GO; GO:0016226; P:iron-sulfur cluster assembly; TAS:ARUK-UCL. DR FunFam; 1.20.990.10:FF:000008; NADPH-dependent diflavin oxidoreductase 1; 1. DR FunFam; 3.40.50.360:FF:000015; NADPH-dependent diflavin oxidoreductase 1; 1. DR FunFam; 3.40.50.80:FF:000055; NADPH-dependent diflavin oxidoreductase 1; 1. DR Gene3D; 3.40.50.360; -; 1. DR Gene3D; 1.20.990.10; NADPH-cytochrome p450 Reductase, Chain A, domain 3; 1. DR Gene3D; 3.40.50.80; Nucleotide-binding domain of ferredoxin-NADP reductase (FNR) module; 1. DR Gene3D; 2.40.30.10; Translation factors; 1. DR HAMAP; MF_03178; NDOR1; 1. DR InterPro; IPR003097; CysJ-like_FAD-binding. DR InterPro; IPR017927; FAD-bd_FR_type. DR InterPro; IPR001094; Flavdoxin-like. DR InterPro; IPR008254; Flavodoxin/NO_synth. DR InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase. DR InterPro; IPR029039; Flavoprotein-like_sf. DR InterPro; IPR039261; FNR_nucleotide-bd. DR InterPro; IPR023173; NADPH_Cyt_P450_Rdtase_alpha. DR InterPro; IPR028879; NDOR1. DR InterPro; IPR001433; OxRdtase_FAD/NAD-bd. DR InterPro; IPR017938; Riboflavin_synthase-like_b-brl. DR PANTHER; PTHR19384:SF10; NADPH-DEPENDENT DIFLAVIN OXIDOREDUCTASE 1; 1. DR PANTHER; PTHR19384; NITRIC OXIDE SYNTHASE-RELATED; 1. DR Pfam; PF00667; FAD_binding_1; 1. DR Pfam; PF00258; Flavodoxin_1; 1. DR Pfam; PF00175; NAD_binding_1; 1. DR PRINTS; PR00369; FLAVODOXIN. DR PRINTS; PR00371; FPNCR. DR SUPFAM; SSF52343; Ferredoxin reductase-like, C-terminal NADP-linked domain; 1. DR SUPFAM; SSF52218; Flavoproteins; 1. DR SUPFAM; SSF63380; Riboflavin synthase domain-like; 1. DR PROSITE; PS51384; FAD_FR; 1. DR PROSITE; PS50902; FLAVODOXIN_LIKE; 1. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Cytoplasm; Direct protein sequencing; KW FAD; Flavoprotein; FMN; NADP; Oxidoreductase; Proteomics identification; KW Reference proteome. FT CHAIN 1..597 FT /note="NADPH-dependent diflavin oxidoreductase 1" FT /id="PRO_0000319539" FT DOMAIN 6..150 FT /note="Flavodoxin-like" FT /evidence="ECO:0000255|HAMAP-Rule:MF_03178" FT DOMAIN 206..447 FT /note="FAD-binding FR-type" FT /evidence="ECO:0000255|HAMAP-Rule:MF_03178" FT REGION 188..207 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 12..17 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000255|HAMAP-Rule:MF_03178, FT ECO:0000269|PubMed:23596212" FT BINDING 59..62 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000255|HAMAP-Rule:MF_03178, FT ECO:0000269|PubMed:23596212" FT BINDING 97..106 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000255|HAMAP-Rule:MF_03178, FT ECO:0000269|PubMed:23596212" FT BINDING 132 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000255|HAMAP-Rule:MF_03178, FT ECO:0000269|PubMed:23596212" FT BINDING 350 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000255|HAMAP-Rule:MF_03178" FT BINDING 382..385 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000255|HAMAP-Rule:MF_03178" FT BINDING 416..419 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000255|HAMAP-Rule:MF_03178" FT BINDING 460 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000255|HAMAP-Rule:MF_03178" FT BINDING 515..516 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000255|HAMAP-Rule:MF_03178" FT BINDING 521..525 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000255|HAMAP-Rule:MF_03178" FT BINDING 558 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000255|HAMAP-Rule:MF_03178" FT BINDING 596 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000255|HAMAP-Rule:MF_03178" FT VAR_SEQ 138..171 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_046313" FT VAR_SEQ 392..398 FT /note="Missing (in isoform 4)" FT /evidence="ECO:0000305" FT /id="VSP_053807" FT VAR_SEQ 518 FT /note="Q -> QPPALFSALQ (in isoform 2)" FT /evidence="ECO:0000303|PubMed:12871939" FT /id="VSP_031487" FT VAR_SEQ 543..597 FT /note="GAYFYLAGNAKSMPADVSEALMSIFQEEGGLCSPDAAAYLARLQQTRRFQTE FT TWA -> ATPSPCQRTSRKP (in isoform 3)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_046314" FT VARIANT 522 FT /note="V -> I (in allele NDOR1*1; shows a decrease in FT affinity for NADPH and a reduction in ferricyanide FT reductase activity; dbSNP:rs62587579)" FT /evidence="ECO:0000269|PubMed:15489334, FT ECO:0000269|PubMed:15900210" FT /id="VAR_039010" FT STRAND 5..11 FT /evidence="ECO:0007829|PDB:4H2D" FT STRAND 13..15 FT /evidence="ECO:0007829|PDB:4H2D" FT HELIX 16..30 FT /evidence="ECO:0007829|PDB:4H2D" FT STRAND 34..39 FT /evidence="ECO:0007829|PDB:4H2D" FT TURN 40..42 FT /evidence="ECO:0007829|PDB:4H2D" FT HELIX 45..50 FT /evidence="ECO:0007829|PDB:4H2D" FT STRAND 52..59 FT /evidence="ECO:0007829|PDB:4H2D" FT HELIX 62..64 FT /evidence="ECO:0007829|PDB:4H2D" FT HELIX 68..70 FT /evidence="ECO:0007829|PDB:4H2D" FT HELIX 71..77 FT /evidence="ECO:0007829|PDB:4H2D" FT TURN 84..89 FT /evidence="ECO:0007829|PDB:4H2D" FT STRAND 91..98 FT /evidence="ECO:0007829|PDB:4H2D" FT STRAND 102..104 FT /evidence="ECO:0007829|PDB:4H2D" FT HELIX 107..118 FT /evidence="ECO:0007829|PDB:4H2D" FT STRAND 122..125 FT /evidence="ECO:0007829|PDB:4H2D" FT STRAND 128..131 FT /evidence="ECO:0007829|PDB:4H2D" FT TURN 135..138 FT /evidence="ECO:0007829|PDB:4H2D" FT HELIX 139..156 FT /evidence="ECO:0007829|PDB:4H2D" SQ SEQUENCE 597 AA; 66763 MW; 0D1340D7280A4D8F CRC64; MPSPQLLVLF GSQTGTAQDV SERLGREARR RRLGCRVQAL DSYPVVNLIN EPLVIFVCAT TGQGDPPDNM KNFWRFIFRK NLPSTALCQM DFAVLGLGDS SYAKFNFVAK KLHRRLLQLG GSALLPVCLG DDQHELGPDA AVDPWLRDLW DRVLGLYPPP PGLTEIPPGV PLPSKFTLLF LQEAPSTGSE GQRVAHPGSQ EPPSESKPFL APMISNQRVT GPSHFQDVRL IEFDILGSGI SFAAGDVVLI QPSNSAAHVQ RFCQVLGLDP DQLFMLQPRE PDVSSPTRLP QPCSMRHLVS HYLDIASVPR RSFFELLACL SLHELEREKL LEFSSAQGQE ELFEYCNRPR RTILEVLCDF PHTAAAIPPD YLLDLIPVIR PRAFSIASSL LTHPSRLQIL VAVVQFQTRL KEPRRGLCSS WLASLDPGQG PVRVPLWVRP GSLAFPETPD TPVIMVGPGT GVAPFRAAIQ ERVAQGQTGN FLFFGCRWRD QDFYWEAEWQ ELEKRDCLTL IPAFSREQEQ KVYVQHRLRE LGSLVWELLD RQGAYFYLAG NAKSMPADVS EALMSIFQEE GGLCSPDAAA YLARLQQTRR FQTETWA // ID SBP1_HUMAN Reviewed; 472 AA. AC Q13228; A6NML9; A6PVW9; B2RDR3; B4DKP6; B4E1F3; Q49AQ8; Q96GX7; DT 15-JUL-1999, integrated into UniProtKB/Swiss-Prot. DT 29-MAY-2007, sequence version 2. DT 28-JAN-2026, entry version 195. DE RecName: Full=Methanethiol oxidase {ECO:0000303|PubMed:29255262}; DE Short=MTO {ECO:0000303|PubMed:29255262}; DE EC=1.8.3.4 {ECO:0000269|PubMed:29255262}; DE AltName: Full=56 kDa selenium-binding protein; DE Short=SBP56; DE Short=SP56; DE AltName: Full=Selenium-binding protein 1; GN Name=SELENBP1; Synonyms=SBP; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC TISSUE=Heart; RX PubMed=9027582; RX DOI=10.1002/(sici)1097-4644(199702)64:2<217::aid-jcb5>3.0.co;2-#; RA Chang P.W.G., Tsui S.K.W., Liew C., Lee C., Waye M.M.Y., Fung K.; RT "Isolation, characterization, and chromosomal mapping of a novel cDNA clone RT encoding human selenium binding protein."; RL J. Cell. Biochem. 64:217-224(1997). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RA Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.; RT "Cloning of human full open reading frames in Gateway(TM) system entry RT vector (pDONR201)."; RL Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4). RC TISSUE=Colon, Lung, and Synovial cell; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16710414; DOI=10.1038/nature04727; RA Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., RA Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., RA Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K., RA Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., RA Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., RA Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., RA Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., RA Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., RA Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., RA Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., RA Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., RA Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., RA Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., RA Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., RA Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., RA Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., RA Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., RA Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., RA McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., RA Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., RA Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., RA Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., RA Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., RA Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., RA White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., RA Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., RA Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., RA Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.; RT "The DNA sequence and biological annotation of human chromosome 1."; RL Nature 441:315-321(2006). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). RC TISSUE=Colon, and Testis; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP PROTEIN SEQUENCE OF 255-276, AND IDENTIFICATION BY MASS SPECTROMETRY. RC TISSUE=Brain, and Cajal-Retzius cell; RA Lubec G., Vishwanath V.; RL Submitted (MAR-2007) to UniProtKB. RN [8] RP TISSUE SPECIFICITY, AND INDUCTION. RX PubMed=9679983; RA Yang M., Sytkowski A.J.; RT "Differential expression and androgen regulation of the human selenium- RT binding protein gene hSP56 in prostate cancer cells."; RL Cancer Res. 58:3150-3153(1998). RN [9] RP TISSUE SPECIFICITY, SUBCELLULAR LOCATION, PHOSPHORYLATION, AND RP IDENTIFICATION BY MASS SPECTROMETRY. RX PubMed=14991897; DOI=10.1002/path.1524; RA Chen G., Wang H., Miller C.T., Thomas D.G., Gharib T.G., Misek D.E., RA Giordano T.J., Orringer M.B., Hanash S.M., Beer D.G.; RT "Reduced selenium-binding protein 1 expression is associated with poor RT outcome in lung adenocarcinomas."; RL J. Pathol. 202:321-329(2004). RN [10] RP TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION. RX PubMed=16223876; DOI=10.1073/pnas.0507666102; RA Glatt S.J., Everall I.P., Kremen W.S., Corbeil J., Sasik R., Khanlou N., RA Han M., Liew C.-C., Tsuang M.T.; RT "Comparative gene expression analysis of blood and brain provides RT concurrent validation of SELENBP1 up-regulation in schizophrenia."; RL Proc. Natl. Acad. Sci. U.S.A. 102:15533-15538(2005). RN [11] RP TISSUE SPECIFICITY, AND IDENTIFICATION BY MASS SPECTROMETRY. RX PubMed=16380993; DOI=10.1002/ijc.21671; RA Huang K.-C., Park D.C., Ng S.-K., Lee J.Y., Ni X., Ng W.-C., Bandera C.A., RA Welch W.R., Berkowitz R.S., Mok S.C., Ng S.-W.; RT "Selenium binding protein 1 in ovarian cancer."; RL Int. J. Cancer 118:2433-2440(2006). RN [12] RP TISSUE SPECIFICITY, AND IDENTIFICATION BY MASS SPECTROMETRY. RX PubMed=16645984; DOI=10.1002/pmic.200500629; RA Kim H., Kang H.J., You K.T., Kim S.H., Lee K.Y., Kim T.I., Kim C., RA Song S.Y., Kim H.-J., Lee C., Kim H.; RT "Suppression of human selenium-binding protein 1 is a late event in RT colorectal carcinogenesis and is associated with poor survival."; RL Proteomics 6:3466-3476(2006). RN [13] RP INTERACTION WITH USP33. RX PubMed=19118533; DOI=10.1016/j.bbrc.2008.12.110; RA Jeong J.Y., Wang Y., Sytkowski A.J.; RT "Human selenium binding protein-1 (hSP56) interacts with VDU1 in a RT selenium-dependent manner."; RL Biochem. Biophys. Res. Commun. 379:583-588(2009). RN [14] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [15] RP ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR RP METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY RP [LARGE SCALE ANALYSIS]. RX PubMed=22814378; DOI=10.1073/pnas.1210303109; RA Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A., RA Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E., RA Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.; RT "N-terminal acetylome analyses and functional insights of the N-terminal RT acetyltransferase NatB."; RL Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012). RN [16] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-111 AND SER-371, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [17] RP FUNCTION, CATALYTIC ACTIVITY, PATHWAY, TISSUE SPECIFICITY, INVOLVEMENT IN RP EHMTO, VARIANTS EHMTO TRP-225; TYR-329 AND 347-GLY--ILE-472 DEL, RP CHARACTERIZATION OF VARIANTS EHMTO TRP-225; TYR-329 AND 347-GLY--ILE-472 RP DEL, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=29255262; DOI=10.1038/s41588-017-0006-7; RA Pol A., Renkema G.H., Tangerman A., Winkel E.G., Engelke U.F., RA de Brouwer A.P.M., Lloyd K.C., Araiza R.S., van den Heuvel L., Omran H., RA Olbrich H., Oude Elberink M., Gilissen C., Rodenburg R.J., Sass J.O., RA Schwab K.O., Schaefer H., Venselaar H., Sequeira J.S., Op den Camp H.J.M., RA Wevers R.A.; RT "Mutations in SELENBP1, encoding a novel human methanethiol oxidase, cause RT extraoral halitosis."; RL Nat. Genet. 50:120-129(2018). CC -!- FUNCTION: Catalyzes the oxidation of methanethiol, an organosulfur CC compound known to be produced in substantial amounts by gut bacteria CC (PubMed:29255262). Selenium-binding protein which may be involved in CC the sensing of reactive xenobiotics in the cytoplasm. May be involved CC in intra-Golgi protein transport (By similarity). CC {ECO:0000250|UniProtKB:Q8VIF7, ECO:0000269|PubMed:29255262}. CC -!- CATALYTIC ACTIVITY: CC Reaction=methanethiol + O2 + H2O = hydrogen sulfide + formaldehyde + CC H2O2 + H(+); Xref=Rhea:RHEA:11812, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16007, CC ChEBI:CHEBI:16240, ChEBI:CHEBI:16842, ChEBI:CHEBI:29919; EC=1.8.3.4; CC Evidence={ECO:0000269|PubMed:29255262}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=4.8 nM for methanethiol {ECO:0000269|PubMed:29255262}; CC -!- PATHWAY: Organosulfur degradation. {ECO:0000269|PubMed:29255262}. CC -!- SUBUNIT: Interacts with USP33. {ECO:0000269|PubMed:19118533}. CC -!- INTERACTION: CC Q13228; Q9UJ68: MSRA; NbExp=3; IntAct=EBI-711619, EBI-19157918; CC Q13228; O43422: THAP12; NbExp=3; IntAct=EBI-711619, EBI-2828217; CC Q13228; Q15645: TRIP13; NbExp=6; IntAct=EBI-711619, EBI-358993; CC Q13228; Q8TEY7-2: USP33; NbExp=5; IntAct=EBI-711619, EBI-719307; CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14991897}. Cytoplasm, CC cytosol {ECO:0000269|PubMed:14991897, ECO:0000269|PubMed:16223876}. CC Membrane {ECO:0000250|UniProtKB:Q8VIF7}; Peripheral membrane protein CC {ECO:0000250|UniProtKB:Q8VIF7}. Note=May associate with Golgi membrane CC (By similarity). May associate with the membrane of autophagosomes (By CC similarity). {ECO:0000250|UniProtKB:Q8VIF7}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=4; CC Name=1; CC IsoId=Q13228-1; Sequence=Displayed; CC Name=2; CC IsoId=Q13228-2; Sequence=VSP_038440; CC Name=3; CC IsoId=Q13228-3; Sequence=VSP_045425; CC Name=4; CC IsoId=Q13228-4; Sequence=VSP_055126; CC -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in liver, lung, CC colon, prostate, kidney and pancreas. In brain, present both in neurons CC and glia (at protein level). Down-regulated in lung adenocarcinoma, CC colorectal carcinoma and ovarian cancer. Two-fold up-regulated in brain CC and blood from schizophrenia patients. {ECO:0000269|PubMed:14991897, CC ECO:0000269|PubMed:16223876, ECO:0000269|PubMed:16380993, CC ECO:0000269|PubMed:16645984, ECO:0000269|PubMed:29255262, CC ECO:0000269|PubMed:9679983}. CC -!- INDUCTION: Down-regulated by androgen in prostate cancer cells. CC {ECO:0000269|PubMed:9679983}. CC -!- PTM: Phosphorylated. {ECO:0000305|PubMed:14991897}. CC -!- PTM: The N-terminus is blocked. {ECO:0000250}. CC -!- DISEASE: Extraoral halitosis due to methanethiol oxidase deficiency CC (EHMTO) [MIM:618148]: An autosomal recessive malodor condition CC characterized by extraoral blood-borne halitosis resulting from the CC accumulation of sulfur-containing metabolites. In extraoral blood-borne CC halitosis, malodorant compounds are carried to the lungs, where they CC enter the breath. Affected individuals have a cabbage-like breath odor, CC high levels of methanethiol and dimethylsulfide in oral and nasal CC breath, and elevated urinary excretion of dimethylsulfoxide in the CC absence of intake of dimethylsulfide-containing food or use of sulfur- CC containing medication, lower-gastrointestinal problems, and known CC metabolic defects, such as methionine adenosyltransferase deficiency CC and tyrosinemia. {ECO:0000269|PubMed:29255262}. Note=The disease is CC caused by variants affecting the gene represented in this entry. CC -!- SIMILARITY: Belongs to the selenium-binding protein family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U29091; AAB02395.1; -; mRNA. DR EMBL; CR456852; CAG33133.1; -; mRNA. DR EMBL; AK296661; BAG59258.1; -; mRNA. DR EMBL; AK303815; BAG64765.1; -; mRNA. DR EMBL; AK315643; BAG38010.1; -; mRNA. DR EMBL; AL391069; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471121; EAW53443.1; -; Genomic_DNA. DR EMBL; CH471121; EAW53445.1; -; Genomic_DNA. DR EMBL; BC009084; AAH09084.1; -; mRNA. DR EMBL; BC032997; AAH32997.1; -; mRNA. DR CCDS; CCDS58027.1; -. [Q13228-3] DR CCDS; CCDS60266.1; -. [Q13228-4] DR CCDS; CCDS995.1; -. [Q13228-1] DR PIR; G01872; G01872. DR RefSeq; NP_001245217.1; NM_001258288.2. [Q13228-3] DR RefSeq; NP_001245218.1; NM_001258289.2. [Q13228-4] DR RefSeq; NP_003935.2; NM_003944.3. [Q13228-1] DR AlphaFoldDB; Q13228; -. DR SMR; Q13228; -. DR BioGRID; 114472; 214. DR CORUM; Q13228; -. DR FunCoup; Q13228; 548. DR IntAct; Q13228; 108. DR MINT; Q13228; -. DR STRING; 9606.ENSP00000397261; -. DR GlyGen; Q13228; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q13228; -. DR PhosphoSitePlus; Q13228; -. DR SwissPalm; Q13228; -. DR BioMuta; SELENBP1; -. DR DMDM; 148840437; -. DR REPRODUCTION-2DPAGE; IPI00012303; -. DR REPRODUCTION-2DPAGE; Q13228; -. DR jPOST; Q13228; -. DR MassIVE; Q13228; -. DR PaxDb; 9606-ENSP00000397261; -. DR PeptideAtlas; Q13228; -. DR ProteomicsDB; 1722; -. DR ProteomicsDB; 5753; -. DR ProteomicsDB; 59234; -. [Q13228-1] DR ProteomicsDB; 59235; -. [Q13228-2] DR Pumba; Q13228; -. DR Antibodypedia; 1584; 393 antibodies from 30 providers. DR DNASU; 8991; -. DR Ensembl; ENST00000368868.10; ENSP00000357861.5; ENSG00000143416.22. [Q13228-1] DR Ensembl; ENST00000426705.6; ENSP00000397261.2; ENSG00000143416.22. [Q13228-4] DR Ensembl; ENST00000447402.7; ENSP00000413960.3; ENSG00000143416.22. [Q13228-3] DR GeneID; 8991; -. DR KEGG; hsa:8991; -. DR MANE-Select; ENST00000368868.10; ENSP00000357861.5; NM_003944.4; NP_003935.2. DR UCSC; uc010pcy.4; human. [Q13228-1] DR AGR; HGNC:10719; -. DR ClinPGx; PA35641; -. DR CTD; 8991; -. DR DisGeNET; 8991; -. DR GeneCards; SELENBP1; -. DR HGNC; HGNC:10719; SELENBP1. DR HPA; ENSG00000143416; Tissue enhanced (intestine). DR MalaCards; SELENBP1; -. DR MIM; 604188; gene. DR MIM; 618148; phenotype. DR OpenTargets; ENSG00000143416; -. DR Orphanet; 562538; Autosomal recessive extra-oral halitosis. DR VEuPathDB; HostDB:ENSG00000143416; -. DR eggNOG; KOG0918; Eukaryota. DR GeneTree; ENSGT00390000014244; -. DR HOGENOM; CLU_032512_0_0_1; -. DR InParanoid; Q13228; -. DR OMA; AYDFWWH; -. DR OrthoDB; 10252446at2759; -. DR PAN-GO; Q13228; 0 GO annotations based on evolutionary models. DR PhylomeDB; Q13228; -. DR PathwayCommons; Q13228; -. DR SABIO-RK; Q13228; -. DR SignaLink; Q13228; -. DR Agora; ENSG00000143416; Agora Nominated Target for Alzheimer's Disease. DR BioGRID-ORCS; 8991; 20 hits in 1164 CRISPR screens. DR ChiTaRS; SELENBP1; human. DR GeneWiki; SELENBP1; -. DR GenomeRNAi; 8991; -. DR Pharos; Q13228; Tbio. DR PRO; PR:Q13228; -. DR Proteomes; UP000005640; Chromosome 1. DR RNAct; Q13228; protein. DR Bgee; ENSG00000143416; Expressed in mucosa of transverse colon and 202 other cell types or tissues. DR ExpressionAtlas; Q13228; baseline and differential. DR GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0005615; C:extracellular space; HDA:UniProtKB. DR GO; GO:0001650; C:fibrillar center; IDA:HPA. DR GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005730; C:nucleolus; IDA:HPA. DR GO; GO:0018549; F:methanethiol oxidase activity; IMP:FlyBase. DR GO; GO:0008430; F:selenium binding; TAS:ProtInc. DR GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW. DR InterPro; IPR008826; Se-bd. DR PANTHER; PTHR23300; METHANETHIOL OXIDASE; 1. DR PANTHER; PTHR23300:SF0; METHANETHIOL OXIDASE; 1. DR Pfam; PF05694; SBP56; 1. DR SUPFAM; SSF75011; 3-carboxy-cis,cis-mucoante lactonizing enzyme; 1. PE 1: Evidence at protein level; KW Acetylation; Alternative splicing; Cytoplasm; Direct protein sequencing; KW Disease variant; Membrane; Nucleus; Oxidoreductase; Phosphoprotein; KW Protein transport; Proteomics identification; Reference proteome; Selenium; KW Transport. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0007744|PubMed:22814378" FT CHAIN 2..472 FT /note="Methanethiol oxidase" FT /id="PRO_0000174633" FT MOD_RES 2 FT /note="N-acetylalanine" FT /evidence="ECO:0007744|PubMed:22814378" FT MOD_RES 111 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:24275569" FT MOD_RES 371 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:24275569" FT MOD_RES 467 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P17563" FT VAR_SEQ 1..64 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_038440" FT VAR_SEQ 1 FT /note="M -> MRLEWGPRPAALPWPAGMCAAERAEGAFTLQSVAQPMRPIAST (in FT isoform 4)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_055126" FT VAR_SEQ 59..120 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_045425" FT VARIANT 225 FT /note="G -> W (in EHMTO; loss of methanethiol oxidation in FT patient cells; dbSNP:rs758495626)" FT /evidence="ECO:0000269|PubMed:29255262" FT /id="VAR_080207" FT VARIANT 329 FT /note="H -> Y (in EHMTO; loss of methanethiol oxidation in FT patient cells; dbSNP:rs1553204840)" FT /evidence="ECO:0000269|PubMed:29255262" FT /id="VAR_080208" FT VARIANT 347..472 FT /note="Missing (in EHMTO; loss of methanethiol oxidation in FT patient cells)" FT /evidence="ECO:0000269|PubMed:29255262" FT /id="VAR_080209" FT CONFLICT 80 FT /note="C -> Y (in Ref. 1; AAB02395)" FT /evidence="ECO:0000305" FT CONFLICT 92 FT /note="T -> N (in Ref. 1; AAB02395)" FT /evidence="ECO:0000305" FT CONFLICT 114..116 FT /note="RAP -> GPQ (in Ref. 1; AAB02395)" FT /evidence="ECO:0000305" FT CONFLICT 135 FT /note="F -> C (in Ref. 1; AAB02395)" FT /evidence="ECO:0000305" FT CONFLICT 260..262 FT /note="DAA -> SAT (in Ref. 1; AAB02395)" FT /evidence="ECO:0000305" FT CONFLICT 270..273 FT /note="LSST -> SAPN (in Ref. 1; AAB02395)" FT /evidence="ECO:0000305" FT CONFLICT 278 FT /note="Y -> C (in Ref. 3; BAG59258)" FT /evidence="ECO:0000305" FT CONFLICT 280..282 FT /note="NEG -> TRE (in Ref. 1; AAB02395)" FT /evidence="ECO:0000305" FT CONFLICT 305..306 FT /note="EM -> GV (in Ref. 1; AAB02395)" FT /evidence="ECO:0000305" FT CONFLICT 410 FT /note="D -> E (in Ref. 1; AAB02395)" FT /evidence="ECO:0000305" FT CONFLICT 442 FT /note="F -> C (in Ref. 1; AAB02395)" FT /evidence="ECO:0000305" SQ SEQUENCE 472 AA; 52391 MW; 6DC68F9B45FEC1BC CRC64; MATKCGNCGP GYSTPLEAMK GPREEIVYLP CIYRNTGTEA PDYLATVDVD PKSPQYCQVI HRLPMPNLKD ELHHSGWNTC SSCFGDSTKS RTKLVLPSLI SSRIYVVDVG SEPRAPKLHK VIEPKDIHAK CELAFLHTSH CLASGEVMIS SLGDVKGNGK GGFVLLDGET FEVKGTWERP GGAAPLGYDF WYQPRHNVMI STEWAAPNVL RDGFNPADVE AGLYGSHLYV WDWQRHEIVQ TLSLKDGLIP LEIRFLHNPD AAQGFVGCAL SSTIQRFYKN EGGTWSVEKV IQVPPKKVKG WLLPEMPGLI TDILLSLDDR FLYFSNWLHG DLRQYDISDP QRPRLTGQLF LGGSIVKGGP VQVLEDEELK SQPEPLVVKG KRVAGGPQMI QLSLDGKRLY ITTSLYSAWD KQFYPDLIRE GSVMLQVDVD TVKGGLKLNP NFLVDFGKEP LGPALAHELR YPGGDCSSDI WI //